Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Leo Pharma Aktiebolag
AB
Active
Org 5560754318
Hyllie Stationstorg 31, 215 32
Malmö
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1960
21 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Leo Pharma Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
54M
108M
162M
216M
188M
2020
173M
2021
158M
2022
154M
2023
163M
2024
EBITDA
SEK millions
0M
3M
5M
8M
10M
9M
2020
8M
2021
6M
2022
6M
2023
6M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
188 234
173 369
157 865
153 555
163 358
Staff expenses
—
—
—
—
—
EBITDA
8 757
8 112
6 443
5 851
6 258
Depreciation & amort.
—
—
—
—
—
EBIT
8 757
8 112
6 443
5 851
6 258
Net financials
−425
−471
−2 535
−1 736
−2 257
Profit before tax
5 548
5 483
6 195
4 251
5 240
Tax
−1 531
−1 341
−1 864
−1 099
−1 374
Net profit
4 017
4 142
4 331
3 152
3 866
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
101 865
208 845
132 245
101 174
91 735
Equity
15 147
19 288
23 619
26 771
30 637
Long-term debt
10 757
65 605
9 697
0
7 706
Short-term debt
52 697
97 831
81 858
59 600
37 890
Total debt
63 454
163 436
91 555
59 600
45 596
Financial ratios
5-year trend
EBITDA margin
3.8%
This company
15.8%
Market median
-76% vs market
2020
2024
Equity ratio
33.4%
This company
38.2%
Market median
+13% vs market
2020
2024
Return on equity
12.6%
This company
18.4%
Market median
+32% vs market
2020
2024
Net profit margin
2.4%
This company
8.1%
Market median
-70% vs market
2020
2024
Asset turnover
1.78×
This company
1.12×
Market median
+59% vs market
2020
2024
Debt / equity
1.99×
This company
0.62×
Market median
-221% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Leo Pharma Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
